Brainomix e-Lung better identifies lung fibrosis patients at risk of decline
A research collaboration between Brainomix and AstraZeneca has shown that Brainomix’s AI-powered e-Lung software can more accurately identify lung fibrosis patients most at risk of decline.Brainomix published a study in the peer-reviewed journal ‘American…
Continue Reading